Skip to main navigation

About
our medicine
science & pipeline
Patients
healthcare professionals
Investors
Careers

About
our medicine
science & pipeline
Patients
healthcare professionals
Investors
Careers

News Releases

Year

October 9, 2026

PDF Version

X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders

October 8, 2026

PDF Version

X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures

October 1, 2026

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 9, 2026

PDF Version

X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference

September 8, 2026

PDF Version

X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting

September 1, 2026

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 6, 2026

PDF Version

X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 3, 2026

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 7, 2026

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 1, 2026

PDF Version

X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 21

quick links

Quick Links

About
Patients
Investors
Careers

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134 Phone: 857.529.8300

© 2026 X4 Pharmaceuticals, Inc. All rights reserved.

Live - Footer

Terms of Use | Privacy | Compliance and Ethics